Advertisement
Advertisement

SLRX

SLRX logo

Salarius Pharmaceuticals Inc

1.24
USD
-0.09
-6.77%
Dec 18, 11:40 UTC -5
Open

Salarius Pharmaceuticals Inc Profile

About

Salarius Pharmaceuticals Inc. is a clinical-stage oncology company. It develops therapies for the treatment of cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals Inc., formerly known as Flex Pharma Inc., is based in Houston, Texas.

Info & Links

CEO

David J. Arthur

Headquarters

2450 Holcombe Blvd., Suite X
Houston, TX 77021, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.salariuspharma.com

Auditor

Ernst & Young LLP

Share holders

149

Employees

2

Salarius Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

1.79M

Enterprise Value

-1.17M

Enterprise Value/EBITDA(ttm)

0.22

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.72

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-140.28%

Return on Invested Capital(ttm)

-156.88%

Return on Assets(ttm)

-105.76%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-5.21M

Net Income Available to Common(ttm)

-4.99M

Diluted EPS(ttm)

-8.17

Share Statistics

Beta (5Y Monthly)

0.92

52-Week Change

-77.38%

S&P 500 52-Week Change

27.88%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.44M

Dividend Yield

0.00%

Float4

1.42M

% Held by Insiders

1.38%

% Held by Institutions

11.88%

Balance Sheet

Total Cash(mrq)

3.28M

Total Cash Per Share(mrq)

2.28

Total Debt(mrq)

328.80K

Total Debt/Equity(mrq)

11.24%

Current Ratio(mrq)

4.09%

Quick Ratio(mrq)

4.09%

Book Value Per Share(mrq)

2.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.95

Free Cash Flow(ytd)

-3.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement